Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling is a research paper published in Cells (2019). On theSindex it has a DataRank of 0.542. It has been cited 36 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Fundação para a Ciência e a Tecnologia, I.P.
Grant: SFRH/BPD/108351/2015
Exploring RKIP protein as a novel predictor of oncogene targeted therapies in cancer
Fundação para a Ciência e a Tecnologia, I.P.
Grant: SFRH/BD/141200/2018
Raf Kinase Inhibitory Protein (RKIP) as a modulator of tumor microenvironment and therapy response in cervical cancer
FWCI
1.52
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals